image: Carlos Collet, MD, PhD, Joins CRF® as Director, Cardiovascular Imaging, Physiology and Translational Therapeutics
Credit: Cardiovascular Research Foundation
NEW YORK – September 9, 2025 – The Cardiovascular Research Foundation® (CRF®) is proud to announce the appointment of Dr. Carlos Collet as Director, Cardiovascular Imaging, Physiology and Translational Therapeutics. A globally recognized interventional cardiologist and imaging expert, Dr. Collet will spearhead efforts to accelerate the integration of cutting-edge research into clinical practice, elevate CRF®’s academic contributions, and expand its global leadership in cardiovascular education. His work will unify translational science, technological innovation, and education to advance CRF®’s mission.
“Dr. Collet is a globally recognized expert in coronary CT, a groundbreaking imaging technology that is revolutionizing how we diagnose and treat cardiovascular disease,” said Juan F. Granada, MD, President and Chief Executive Officer of CRF®. “His deep expertise will not only ensure strong leadership of our imaging and physiology programs but also drive CRF® into new frontiers of innovation reinforcing our position as a global leader in cardiovascular research and care.”
Dr. Collet will support all initiatives across CRF®’s divisions, leveraging his expertise to strengthen scientific excellence and innovation throughout the organization.
“We’re thrilled to welcome Dr. Collet as he takes on a pivotal leadership role within our core labs,” said Alexandra Popma, MD, Executive Director of the CRF® Clinical Trials Center. “Dr. Collet will lead the expansion of our imaging capabilities by introducing novel coronary and endovascular services. His exceptional blend of clinical insight and scientific leadership will be instrumental in driving innovation and improving patient outcomes. This appointment marks a significant step forward in our mission to deliver cutting-edge cardiovascular research, education, and care.”
A distinguished interventional cardiologist with a global reputation for excellence in cardiovascular physiology, imaging, and research, Dr. Collet has authored over 300 peer-reviewed publications. He most recently served as co-director of the catheterization laboratory at the Cardiovascular Center OLV Aalst in Belgium. Dr. Collet completed his medical training at the Dante Pazzanese Institute of Cardiology in São Paulo, Brazil, with a specialization in interventional cardiology. He later pursued advanced training in cardiac computed tomography angiography at Holy Cross Hospital in Florida and earned a PhD in Cardiovascular Sciences from the University of Amsterdam, where his research focused on integrating coronary imaging and physiology in complex coronary artery disease.
“I’m honored to join CRF® and contribute to its mission of advancing cardiovascular care through innovation, research, and education,” said Dr. Carlos Collet. “This is a unique opportunity to build on the foundation of excellence already established within the core labs, while expanding our coronary and endovascular imaging capabilities. Together, we will continue to develop new platforms for discovery and deliver more personalized, impactful care to patients around the world.”
About CRF®
The Cardiovascular Research Foundation® (CRF®) is a global leader in interventional cardiovascular medicine, driving innovation, spearheading groundbreaking research, and transforming education in the field. Through its relentless pursuit of excellence, CRF® not only accelerates medical breakthroughs but also equips healthcare professionals with the tools and knowledge necessary to enhance survival rates and elevate the quality of life for millions worldwide. CRF®’s centers of excellence include the CRF® Skirball Center for Innovation, CRF® Clinical Trials Center, CRF® Center for Education, CRF® Digital, TCTMD®, and Structural Heart: The Journal of the Heart Team.
###